This cohort study evaluates if a noninvasive test for nonalcoholic steatohepatitis and hepatic fibrosis can be used in patients with psoriasis to aid in determining eligibility for methotrexate therapy, monitor for development of methotrexate-induced hepatotoxic effects, and monitor for worsening of hepatic fibrosis scores during methotrexate therapy.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.